The collaboration will leverage BIND’s Medicinal Nanoengineering technology for the addition of tissue and cellular targeting capabilities to molecularly targeted drugs. BIND president and CEO Scott Minick said
The second CDI facility forms part of the $16m grant from California Institute of Regenerative Medicine (CIRM) to create and bank human induced pluripotent stem cells (iPSCs). Cellular
Achieved through a Type II variation, the production site approval will allow Pharming to supply the European market with drug substance from Sanofi Chimie. The approval will also
Commending FDA recommendation, GlaxoSmithKline (GSK) Consumer Healthcare said the action would be a positive step to help smokers to quit smoking and it will work with the FDA
According to the researchers though many medicines have one active ingredient, the combination of medicines may contain more than one active ingredient. Due to the adverse effects of
Tier One National spokesperson Simon Harris said, "We are excited to partner with Nirogam India Pvt. Ltd because they purchase their products from reliable market vendors who make
The retrieval of rights is based on Daiichi’s decision to conclude a license and co-commercialization agreement with ArQule. ArQule chief medical officer Brian Schwartz said, "AKT, also known
The site displays all kinds of weight loss supplements from fat burners to appetite suppressants, according to the company. Weight Loss Pills Canada spokesperson said research, product testing,
As part of the proposed $180m investment, Lilly would add second insulin cartridge-filling line in addition to one under previously announced $140m expansion. The company also expects to
LabCorp chief medical officer Dr. Mark Brecher said, "We are excited to expand our relationship with Bristol-Myers Squibb to provide a more flexible and integrated approach to laboratory
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.